Entity

Time filter

Source Type

Cheshire, CT, United States

Patent
Progenics Pharmaceuticals Inc. and Wyeth Llc | Date: 2015-08-07

The present invention provides a new forms of (R)N-methylnaltrexone, and compositions thereof, useful as a peripheral mu opioid receptor antagonist.


Patent
Progenics Pharmaceuticals. Inc. | Date: 2013-06-06

This invention relates to synthesis of (R),(R)-2,2-bis-MNTX, as shown in Formula (I), and related methods and products.


Patent
Progenics Pharmaceuticals Inc. | Date: 2015-06-22

This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.


Patent
Progenics Pharmaceuticals Inc. | Date: 2012-11-07

This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.


Patent
Wyeth Llc and Progenics Pharmaceuticals Inc. | Date: 2013-09-04

The present invention provides a compound of formula I: wherein R

Discover hidden collaborations